Coacervate delivery systems for proteins and small molecule drugs

Expert Opinion on Drug Delivery

Volumn 11, Issue 12, 2014, Pages 1829-1832

  Johnson, Noah R ^a,b   Wang, Yadong ^a,b,c  

^a University of Pittsburgh   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Chitosan; Coacervate; Controlled release; Doxorubicin; Drug delivery; Elastin; Growth factor; Heparin; Hyaluronic acid

Indexed keywords

CHITOSAN; DENDRIMER; ELASTIN LIKE PEPTIDE; GROWTH FACTOR; HEPARIN; HYALURONIC ACID; LIPOSOME; MUSSEL ADHESIVE PROTEIN; NANOPARTICLE; NEW DRUG; POLYCATION; PROTEIN; UNCLASSIFIED DRUG; ADHESIVE PROTEIN, MUSSEL; CARBOXYMETHYL-CHITOSAN; COLLOID; DRUG CARRIER; ELASTIN;

BIOLOGICAL ACTIVITY; CELL THERAPY; COACERVATION; DRUG DELIVERY SYSTEM; HYDROGEL; REVIEW; TISSUE ENGINEERING; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; COLLOID; HUMAN;

ANIMALS; CHITOSAN; COLLOIDS; DRUG CARRIERS; ELASTIN; HEPARIN; HUMANS; PROTEINS;

EID: 84911460820     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.941355     Document Type: Review

References (30)

1. Overbeek JT, Voorn MJ. Phase separation in polyelectrolyte solutions. Theory of complex coacervation. J Cell Comp Physiol 1957;49(S1):7-26
2. De Kruif CG, Weinbreck F, De Vries R. Complex coacervation of proteins and anionic polysaccharides. Curr Opin Colloid Interface Sci 2004;9(5):340-9
3. Liu G, An Z. Frontiers in the design and synthesis of advanced nanogels for nanomedicine. Polym Chem 2014;5(5):1559-65
4. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005;4(7):581-93
5. McClements DJ, Li Y. Structured emulsion-based delivery systems: controlling the digestion and release of lipophilic food components. Adv Colloid Interface Sci 2010;159(2):213-28
6. Urry DW. Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. J Phys Chem B 1997;101(51):11007-28
7. MacEwan SR, Chilkoti A. Elastin-like polypeptides: biomedical applications of tunable biopolymers. Biopolymers 2010;94(1):60-77
8. Urry DW, Luan CH, Parker TM, et al. Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity. J Am Chem Soc 1991;113(11):4346-8
9. McDaniel JR, Callahan DJ, Chilkoti A. Drug delivery to solid tumors by elastin-like polypeptides. Adv Drug Deliv Rev 2010;62(15):1456-67
10. Liu WG, McDaniel J, Li XH, et al. Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides in situ. Cancer Res 2012;72(22):5956-65
11. Meyer DE, Kong GA, Dewhirst MW, et al. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res 2001;61(4):1548-54
12. Dreher MR, Liu W, Michelich CR, et al. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res 2007;67(9):4418-24
13. Betre H, Ong SR, Guilak F, et al. Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials 2006;27(1):91-9
14. Betre H, Setton LA, Meyer DE, Chilkoti A. Characterization of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules 2002;3(5):910-16
15. Ori A, Wilkinson MC, Fernig DG. A systems biology approach for the investigation of the heparin/heparan sulfate interactome. J Biol Chem 2011;286(22):19892-904
16. Chu H, Gao J, Wang Y. Design, synthesis, and biocompatibility of an arginine-based polyester. Biotechnol Prog 2012;28(1):257-64
17. Johnson NR, Ambe T, Wang Y. Lysine-based polycation:heparin coacervate for controlled protein delivery. Acta Biomater 2014;10(1):40-6
18. Chu H, Johnson NR, Mason NS, Wang Y. A [polycation:heparin] complex releases growth factors with enhanced bioactivity. J Control Release 2011;150(2):157-63
19. Zern BJ, Chu HH, Osunkoya AO, et al. A biocompatible arginine-based polycation. Adv Funct Mater 2011;21(3):434-40
20. Chu H, Gao J, Chen CW, et al. Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci USA 2011;108(33):13444-9
21. Chu H, Chen CW, Huard J, Wang Y. The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium. Biomaterials 2013;34(6):1747-56
22. Johnson NR, Wang Y. Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair. PLoS One 2013;8(5):e63075
23. Johnson NR, Wang Y. Controlled delivery of heparin-binding egf-like growth factor yields fast and comprehensive wound healing. J Control Release 2013;166(2):124-9
24. Li H, Johnson NR, Usas A, et al. Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells. Stem Cells Transl Med 2013;2(9):667-77
25. Lee KW, Johnson NR, Gao J, Wang Y. Human progenitor cell recruitment via sdf-1alpha coacervate-laden pgs vascular grafts. Biomaterials 2013;34(38):9877-85
26. Feng C, Wang Z, Jiang C, et al. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Int J Pharm 2013;457(1):158-67
27. Feng C, Song R, Sun G, et al. Immobilization of coacervate microcapsules in multilayer sodium alginate beads for efficient oral anticancer drug delivery. Biomacromolecules 2014;15(3):985-96
28. Lee BP, Messersmith PB, Israelachvili JN, Waite JH. Mussel-inspired adhesives and coatings. Annu Rev Mater Res 2011;41:99-132
29. Lim S, Choi YS, Kang DG, et al. The adhesive properties of coacervated recombinant hybrid mussel adhesive proteins. Biomaterials 2010;31(13):3715-22
30. Hwang DS, Waite JH, Tirrell M. Promotion of osteoblast proliferation on complex coacervation-based hyaluronic acid - recombinant mussel adhesive protein coatings on titanium. Biomaterials 2010;31(6):1080-4